Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919125862Aexternal-prioritypatent/GB9125862D0/en
Priority claimed from GB929213042Aexternal-prioritypatent/GB9213042D0/en
Priority claimed from PCT/GB1992/002234external-prioritypatent/WO1993010757A1/en
Application filed by Smithkline Beecham PlcfiledCriticalSmithkline Beecham Plc
Publication of NO942076LpublicationCriticalpatent/NO942076L/no
Publication of NO942076D0publicationCriticalpatent/NO942076D0/no
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Farmasøytisk blanding omfattende trans-(3S,4R)-3,4- dihydro-2,2-dimetyl-4-(2-oksopiperidin-l-yl)-6-pentafluoretyl- 2H-l-benzopyran-3-ol ("forbindelse I"), eller et farmasøytisk akseptabelt salt derav, eller et farmasøytisk akseptabelt solvat derav, og en farmasøytisk akseptabel bærer for disse, hvori blandingen omfatter 0,2 til 0,9 mg eller 1,1 til 1,9 mg eller 2,1 til 3,0 mg av forbindelse I; en fremgangsmåte for fremstilling av en slik blanding og anvendelsen av en slik blanding i medisin.
Pharmaceutical compositions containing bis(3,4-dihydro-2h-1-benzopyran)derivatives for lowering blood pressure,certain such novel compounds and their preparation
ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient